MODERATE-TO-SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE-TO-SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE-TO-SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE-TO-SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eczema drug shows promise in early trial
Disease control Not yet recruitingThis study tests a new medicine called AK139 for people with moderate to severe atopic dermatitis (eczema). About 168 adults will receive either AK139 or a placebo to see if it safely improves skin symptoms like itching and redness. The trial is in Phase 2 and is not yet recruiti…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
New pill could bring relief to millions with severe eczema
Disease control Not yet recruitingThis study tests an oral medication called LW402 in 480 adults with moderate-to-severe atopic dermatitis (eczema). Participants will receive either the drug or a placebo for 16 weeks. The goal is to see if LW402 can significantly improve skin symptoms like redness, itching, and r…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase: PHASE3 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control Not yet recruitingThis study tests a new medicine called CMS-D001 for adults with moderate to severe eczema (atopic dermatitis) who haven't gotten enough relief from standard creams. About 160 people will receive either the drug or a placebo to see if it improves skin symptoms like redness and itc…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New pill could ease severe eczema symptoms
Symptom relief Not yet recruitingThis study tests an experimental capsule called QLS12010 in 160 adults with moderate-to-severe atopic dermatitis (eczema). Participants will receive either the drug or a placebo for 16 weeks. The main goal is to see if the drug reduces eczema severity and itching better than a pl…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 17, 2026 05:48 UTC